Carbimazole structure
|
Common Name | Carbimazole | ||
---|---|---|---|---|
CAS Number | 22232-54-8 | Molecular Weight | 186.232 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 240.4±23.0 °C at 760 mmHg | |
Molecular Formula | C7H10N2O2S | Melting Point | 124°C | |
MSDS | Chinese USA | Flash Point | 99.2±22.6 °C |
Use of CarbimazoleCarbimazole is an imidazole antithyroid agent. Target: OthersCarbimazole is an effective thyroid hormone inhibitor under a class of drugs known as pro-drugs. It is considered a pro-drug because it converts to methimazole after being absorbed by the body, generating an antithyroid action that works against hyperthyroidism (excessive production of thyroid hormones) and thyrotoxicosis (inflammation of the thyroid gland) [1]. Methimazole prevents the thyroid peroxidase enzyme from coupling and iodinating the tyrosine residues on thyroglobulin, hence reducing the production of the thyroid hormones T3 and T4 (thyroxine) [2].Carbimazole (CBZ) is one of the major drugs currently used for the treatment of Graves' disease. Experiments with [35S] CBZ in rats showed that the drug is so rapidly transformed to MMI after i.v. injection (within 3 min) that very little of the unchanged drug would be expected to reach the thyroid gland. The antithyroid action of CBZ in rats, therefore, can be ascribed entirely to the MMI to which it is rapidly converted [3]. |
Name | carbimazole |
---|---|
Synonym | More Synonyms |
Description | Carbimazole is an imidazole antithyroid agent. Target: OthersCarbimazole is an effective thyroid hormone inhibitor under a class of drugs known as pro-drugs. It is considered a pro-drug because it converts to methimazole after being absorbed by the body, generating an antithyroid action that works against hyperthyroidism (excessive production of thyroid hormones) and thyrotoxicosis (inflammation of the thyroid gland) [1]. Methimazole prevents the thyroid peroxidase enzyme from coupling and iodinating the tyrosine residues on thyroglobulin, hence reducing the production of the thyroid hormones T3 and T4 (thyroxine) [2].Carbimazole (CBZ) is one of the major drugs currently used for the treatment of Graves' disease. Experiments with [35S] CBZ in rats showed that the drug is so rapidly transformed to MMI after i.v. injection (within 3 min) that very little of the unchanged drug would be expected to reach the thyroid gland. The antithyroid action of CBZ in rats, therefore, can be ascribed entirely to the MMI to which it is rapidly converted [3]. |
---|---|
Related Catalog | |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 240.4±23.0 °C at 760 mmHg |
Melting Point | 124°C |
Molecular Formula | C7H10N2O2S |
Molecular Weight | 186.232 |
Flash Point | 99.2±22.6 °C |
Exact Mass | 186.046295 |
PSA | 68.25000 |
LogP | 0.34 |
Vapour Pressure | 0.0±0.5 mmHg at 25°C |
Index of Refraction | 1.612 |
Storage condition | Refrigerator |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
Risk Phrases | R22 |
---|---|
Safety Phrases | S22-S36/37/39 |
RIDADR | 3335 |
RTECS | NJ2441000 |
HS Code | 2922499915 |
~87% Carbimazole CAS#:22232-54-8 |
Literature: Das, Debasis; Roy, Gouriprasanna; Mugesh, Govindasamy Journal of Medicinal Chemistry, 2008 , vol. 51, # 22 p. 7313 - 7317 |
~% Carbimazole CAS#:22232-54-8 |
Literature: Journal of the Chemical Society, , p. 1103,1106 US2671088 , ; US2815349 , ; |
~% Carbimazole CAS#:22232-54-8 |
Literature: Journal of the Chemical Society, , p. 2387,2390 |
~% Carbimazole CAS#:22232-54-8 |
Literature: Journal of the Chemical Society, , p. 1103,1106 US2671088 , ; US2815349 , ; |
~% Carbimazole CAS#:22232-54-8 |
Literature: Journal of the Chemical Society, , p. 2387,2390 |
~% Carbimazole CAS#:22232-54-8 |
Literature: Journal of the Chemical Society, , p. 2387,2390 |
HS Code | 2933290090 |
---|---|
Summary | 2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Gingival pain: an unusual side effect of ziprasidone.
BMJ Case Rep. 2013 , doi:10.1136/bcr-2012-007577, (2013) The patient is a 52-year-old man with schizophrenia who developed severe, unremitting gingival pain after his ziprasidone dosage was increased from 80 to 120 mg. His physical examination and laborator... |
|
A misguided 'pill in the pocket' approach with flecainide leading to cardiac arrest.
BMJ Case Rep. 2012 , doi:10.1136/bcr-2012-006868, (2012)
|
|
The pharmacokinetics of methimazole in a novel lipophilic formulation administered transdermally to healthy cats.
N. Z. Vet. J. 62(4) , 208-13, (2014) To determine the pharmacokinetics of a novel lipophilic formulation of transdermal methimazole compared to oral carbimazole.Healthy cats received 5 mg carbimazole orally every 12 hours for 13 treatmen... |
Carbimazolum |
Ethyl 3-methyl-2-thioxo-2,3-dihydro-1H-imidazole-1-carboxylate |
EINECS 244-854-4 |
Carbimazol |
Carbimazole |
Neo-Thyreostat |
3-Methyl-2-thioxo-2,3-dihydro-imidazol-1-carbonsaeure-aethylester |
1-Methyl-3-carbethoxy-2-thioglyoxalone |
1H-Imidazole-1-carboxylic acid, 2,3-dihydro-3-methyl-2-thioxo-, ethyl ester |
CG 1 |
Thyrostat |
ethyl 3-methyl-2-thionoimidazoline-1-carboxylate |
Carbethoxymethimazole |
3-methyl-2-thioxo-2,3-dihydro-imidazole-1-carboxylic acid ethyl ester |
ethyl 3-methyl-2-sulfanylideneimidazole-1-carboxylate |
3-methyl-1-ethoxycarbonylimidazoline-2-thione |
Carbinazole |
2,3-Dihydro-3-methyl-2-thioxo-1H-imidazole-1-carboxylic Acid Ethyl Ester |
Athyromazole |
1-Ethoxycarbonyl-3-methyl-2-thioxo-4-imidazoline |
MFCD00027421 |
Neomercazole |
1-Ethoxycarbonyl-3-methyl-2-thio-4-imidazoline |